James Jeaho Rhyu - 18 Sep 2025 Form 4 Insider Report for Stride, Inc. (LRN)

Signature
/s/ John C. Grothaus, Attorney-in-fact
Issuer symbol
LRN
Transactions as of
18 Sep 2025
Net transactions value
-$6,366,883
Form type
4
Filing time
19 Sep 2025, 18:36:27 UTC
Previous filing
20 Aug 2025
Next filing
20 Nov 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Rhyu James Jeaho Chief Executive Officer, Director 11720 PLAZA AMERICA DRIVE, 9TH FLOOR, RESTON /s/ John C. Grothaus, Attorney-in-fact 19 Sep 2025 0001443328

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LRN Common Stock Options Exercise $0 +58,395 +8.3% $0.000000 764,748 18 Sep 2025 Direct F1
transaction LRN Common Stock Award $0 +58,395 +7.6% $0.000000 823,143 18 Sep 2025 Direct F1
transaction LRN Common Stock Tax liability $6,366,883 -45,957 -5.6% $138.54 777,186 18 Sep 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LRN Restricted Stock Right Options Exercise $0 -58,395 -100% $0.000000 0 18 Sep 2025 Common Stock 58,395 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the acquisition of shares of Common Stock in connection with the vesting at above target threshold of the performance award originally granted on September 6, 2022.
F2 Represents the number of shares withheld by the Issuer upon the vesting of restricted shares to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Stride common stock on the vesting date.
F3 Each restricted stock right represents a contingent right to receive one share of Stride common stock. The restricted stock rights vested based on the achievement of certain compound annual growth rates in the price of the Company's common stock between the award date and September 15, 2025, subject to earlier vesting in certain circumstances described in the applicable award agreement.